The Centers for Disease Control and Prevention (CDC) is going to provide $200 million to jurisdictions for COVID-19 vaccine preparedness. In late August, the CDC advised states to prepare to distribute a vaccine for COVID-19. The CDC indicated a limited supply could be available to states by Nov. 1. Several potential vaccines are currently in Phase 3 trials, which are placebo-controlled, random trials with thousands of participants.
The CDC is awarding $200 million in funding from the Coronavirus Aid, Relief, and Economic Security Act (CARES) to 64 jurisdictions–states, tribes, local jurisdictions, and territories. The CDC will distribute the funds via the existing Immunizations and Vaccines for Children cooperative agreement. The funding is intended for jurisdictions to plan for and implement COVID-19 vaccination services.
Funding will be based on each receiving entity’s population, based on the U.S. Census.
“CDC has worked for decades with state and local jurisdictions to deliver tens of millions of doses of vaccine every year” said CDC Director Robert Redfield. “CDC is working closely with these jurisdictions to refine and update vaccination plans in preparation for the upcoming COVID-19 vaccine program.”
